Zebrafish larvae for drug screening
Description
In this 3RCC-funded project, we aim to reduce the number of rodents employed for the screening of novel antimicrobials using a zebrafish larval model of bacterial infections. We will set up live microscopic imaging readouts to monitor bacterial spread in zebrafish larvae and will use the model to screen novel, bacteriophage-derived antimicrobials regarding efficacy. This will allow to select drug candidates for further preclinical development in zebrafish larvae rather than rodents, thereby significantly reducing the number of mice normally used for this purpose.
Key Data
Projectlead
Deputy Projectlead
Dr. Patrick Hauswirth, Boris Pasini, Dr. Marjan Veljkovic
Project team
Project status
ongoing, started 05/2024
Institute/Centre
Institute of Chemistry and Biotechnology (ICBT); Institute of Food and Beverage Innovation (ILGI); Institute of Natural Resource Sciences (IUNR)
Funding partner
Other